Literature DB >> 10221323

Group A Streptococcus carriage among close contacts of patients with invasive infections.

K Weiss1, M Laverdière, M Lovgren, J Delorme, L Poirier, C Béliveau.   

Abstract

During the past few years, the incidence of invasive group A Streptococcus (GAS) infection has been increasing. However, there are presently no clear recommendations regarding antibiotic prophylaxis for close contacts of index patients. The aims of this study were 1) to determine the prevalence of carriage of the same GAS strain as the patient's among contacts of patients with invasive infections and 2) to assess the importance of exposure duration. From March 1995 to March 1996, the authors prospectively included in the study all patients with invasive GAS infection, as defined by the Working Group on Severe Streptococcal Infections, who came to Hôpital Maisonneuve-Rosemont in Montreal, Quebec, Canada. An epidemiologic investigation was systematically carried out for each index case. Contacts were divided into two groups: those who had spent 24 hours or more with the index patient during the week preceding the beginning of his or her illness and those who had spent 12-24 hours with the index patient during that week. Strains of GAS were examined by serotyping (proteins M and T and the presence or absence of the serum opacity factor) and by characterization of streptococcal pyrogenic exotoxins (exotoxins A, B, and C). One hundred and two contacts of 17 index cases with invasive GAS infection were systematically screened. Contacts were considered positive if they carried the same strain of the bacterium and the same streptococcal pyrogenic exotoxin as the index case. Among the contacts who had spent at least 24 hours per week with their respective index cases, 13 out of 48 (27%) were found to be harboring the same serotype of GAS as the index patient (95% confidence interval 14.5-39.5). By comparison, only one of the 54 contacts in the 12- to 24-hour group (1.8%) was found to be carrying the same strain of the bacterium (95% confidence interval 0-5.3). This difference between the two groups was statistically significant (p<0.001). The median age of the positive carriers (10 years) was significantly lower than the median age of the noncarriers (39 years) (p< or =0.0005). This study showed that close contacts who had spent 12-24 hours with the index patient were rarely colonized with GAS. If antibiotic prophylaxis against GAS is recommended, it should probably target contacts who spent at least 24 hours with an infected patient during the week preceding illness onset.

Entities:  

Mesh:

Year:  1999        PMID: 10221323     DOI: 10.1093/oxfordjournals.aje.a009902

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  12 in total

Review 1.  Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens.

Authors:  Vincent A Fischetti
Journal:  Int J Med Microbiol       Date:  2010-05-10       Impact factor: 3.473

Review 2.  Bacteriophage lysins as effective antibacterials.

Authors:  Vincent A Fischetti
Journal:  Curr Opin Microbiol       Date:  2008-10-14       Impact factor: 7.934

3.  Exploiting what phage have evolved to control gram-positive pathogens.

Authors:  Vincent A Fischetti
Journal:  Bacteriophage       Date:  2011-07-01

Review 4.  Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem.

Authors:  Samson Sy Wong; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2012-07-11       Impact factor: 7.163

5.  Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995-2001.

Authors:  Maria-Graciela Hollm-Delgado; Robert Allard; Pierre A Pilon
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

6.  Familial Transmission of emm12 Group A Streptococcus.

Authors:  Claire Duployez; Anne Vachée; Olivier Robineau; François Giraud; Anthony Deny; Eric Senneville; Frédéric Wallet; Caroline Loïez
Journal:  Emerg Infect Dis       Date:  2017-10       Impact factor: 6.883

7.  Vitamin D and the human antimicrobial peptide LL-37 enhance group a streptococcus resistance to killing by human cells.

Authors:  John F Love; Hien J Tran-Winkler; Michael R Wessels
Journal:  mBio       Date:  2012-10-23       Impact factor: 7.867

8.  Invasive group A streptococcal disease: risk factors for adults.

Authors:  Stephanie H Factor; Orin S Levine; Benjamin Schwartz; Lee H Harrison; Monica M Farley; Allison McGeer; Anne Schuchat
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883

9.  Investigation of Scarlet Fever Outbreak in a Kindergarten.

Authors:  Sukhyun Ryu; Byung Chul Chun
Journal:  Infect Chemother       Date:  2018-03

10.  Characteristics of mucoid Streptococcus pyogenes isolated from two patients with pneumonia in a local community.

Authors:  Nobuaki Mori; Sakiko Hosoo; Yoshitaka Oyamada; Yasushi Sera; Yasuhiro Yamada; Momoko Sugawara; Akiko Higuchi; Yasuko Aoki; Takashi Takahashi
Journal:  IDCases       Date:  2016-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.